BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9493034)

  • 1. Evaluation of plasma osmolality and hormone responses in elderly chronic hemodialysis patients with excessive interdialytic weight gain.
    Samuel-Variath R; Chan R; Michelis MF
    Geriatr Nephrol Urol; 1997; 7(3):131-5. PubMed ID: 9493034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of thirst regulation in patients with chronic renal failure on hemodialysis.
    Martinez-Vea A; García C; Gaya J; Rivera F; Oliver JA
    Am J Nephrol; 1992; 12(1-2):73-9. PubMed ID: 1415369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haemodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with end-stage renal disease.
    Iitake K; Kimura T; Matsui K; Ota K; Shoji M; Inoue M; Yoshinaga K
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):207-13. PubMed ID: 3904290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal hemodynamics and elevated angiotensin II plasma levels in polydipsic patients on regular hemodialysis treatment.
    Graziani G; Badalamenti S; Del Bo A; Marabini M; Gazzano G; Como G; Viganò E; Ambroso G; Morganti A
    Kidney Int; 1993 Jul; 44(1):107-14. PubMed ID: 8355450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of thirst in end-stage kidney insufficiency].
    Heidbreder E; Bahner U; Hess M; Geiger H; Götz R; Kirsten R; Rascher W; Heidland A
    Klin Wochenschr; 1990 Nov; 68(22):1127-33. PubMed ID: 2149156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of plasma renin, aldosterone, catecholamines and vasopressin in chronic ambulatory peritoneal dialysis (CAPD) patients.
    Zabetakis PM; Kumar DN; Gleim GW; Gardenswartz MH; Agrawal M; Robinson AG; Michelis MF
    Clin Nephrol; 1987 Sep; 28(3):147-51. PubMed ID: 3311503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure.
    Yamamoto T; Shimizu M; Morioka M; Kitano M; Wakabayashi H; Aizawa N
    JAMA; 1986 Aug; 256(5):604-8. PubMed ID: 3522948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis.
    Fasanella d'Amore T; Wauters JP; Waeber B; Nussberger J; Brunner HR
    Clin Nephrol; 1985 Jun; 23(6):299-302. PubMed ID: 4028528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis.
    Farinelli A; Squerzanti R; De Paoli Vitali E; Bagni B; Cavallini AR; Gilli P; Bedani PL
    Nephron; 1980; 26(6):274-9. PubMed ID: 7005702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of aldosterone secretion in anephric man.
    Bayard F; Cooke CR; Tiller DJ; Beitins IZ; Kowarski A; Walker WG; Migeon CJ
    J Clin Invest; 1971 Aug; 50(8):1585-95. PubMed ID: 4329001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients.
    Van Stone JC; Bauer J; Carey J
    Am J Kidney Dis; 1982 Jul; 2(1):58-64. PubMed ID: 7048902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.
    Manlucu J; Gallo K; Heidenheim PA; Lindsay RM
    Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN; Vaziri ND; Pandian MR; Kaupke J
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of postdialysis serum sodium level and interdialytic weight gain in patients on maintenance hemodialysis.
    Abbas G; Rafiquee Z; Shafi T
    J Coll Physicians Surg Pak; 2007 Aug; 17(8):482-5. PubMed ID: 17785127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between volume status and blood pressure during chronic hemodialysis.
    Leypoldt JK; Cheung AK; Delmez JA; Gassman JJ; Levin NW; Lewis JA; Lewis JL; Rocco MV
    Kidney Int; 2002 Jan; 61(1):266-75. PubMed ID: 11786109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dual blockade of the renin-angiotensin system on thirst in hemodialysis patients.
    Masajtis-Zagajewska A; Nowicki M
    Nephron Clin Pract; 2009; 112(4):c242-7. PubMed ID: 19546583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdialytic weight gain correlates with glycosylated hemoglobin in diabetic hemodialysis patients.
    Ifudu O; Dulin AL; Friedman EA
    Am J Kidney Dis; 1994 May; 23(5):686-91. PubMed ID: 8172211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An equation for calculating postdialysis plasma sodium.
    Lopot F; Bláha J; Válek A
    Int J Artif Organs; 1992 Jun; 15(6):354-7. PubMed ID: 1639527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.